F13A1 and nasal cavity polyp: Expression levels of ALOX5AP, AQP9, CCL13, EMR3, F13A1, GAPT, and NCF2 were significantly higher in nasal polyp samples from ACRSwNP patients compared with the expression levels in samples from healthy subjects.